No photo of Xuejun Wang

View Scopus Profile

Xuejun Wang, PhD, MBBS

  • Professor of Basic Biomedical Sciences, Director USD MD/PhD Program, University of South Dakota, Great Plains IDeA-CTR
 https://orcid.org/0000-0001-9267-1343
  • 11032 Citations
  • 48 h-Index
19962020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Xuejun Wang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects

Molecular Pathogenesis of Protein Surplus Cardiomyopathy

Wang, X.

Project: Research project

Mechanisms of cardiovascular remodeling

Wang, X.

Project: Research project

The NRF2-p62 Axis in the Cross-Talk between Proteasomal and Lysosomal Degradation

Wang, X.

Project: Research project

The COP9 Signalosome in the Heart

Wang, X.

Project: Research project

PROTEIN OXIDATION AND CARDIAC CONTRACTILE DYSFUNCTION

Wang, X.

Project: Research project

Research Output

Priming the Proteasome to Protect against Proteotoxicity

Wang, X. & Wang, H., Jan 1 2020, (Accepted/In press) In : Trends in Molecular Medicine.

Research output: Contribution to journal › Review article

    • Auranofin lethality to prostate cancer includes inhibition of proteasomal deubiquitinases and disrupted androgen receptor signaling

    Liu, N., Guo, Z., Xia, X., Liao, Y., Zhang, F., Huang, C., Liu, Y., Deng, X., Jiang, L., Wang, X., Liu, J. & Huang, H., Mar 5 2019, In : European Journal of Pharmacology. 846, p. 1-11 11 p.

    Research output: Contribution to journal › Article

    • 6 Scopus citations

    Highly dynamic changes in the activity and regulation of macroautophagy in hearts subjected to increased proteotoxic stress

    Pan, B., Lewno, M. T., Wu, P. & Wang, X., Jan 1 2019, In : Frontiers in Physiology. 10, JUN, 758.

    Research output: Contribution to journal › Article

    Open Access
    • 3 Scopus citations

    Inhibition of EGFR signaling with Spautin-1 represents a novel therapeutics for prostate cancer

    Liao, Y., Guo, Z., Xia, X., Liu, Y., Huang, C., Jiang, L., Wang, X., Liu, J. & Huang, H., Apr 11 2019, In : Journal of Experimental and Clinical Cancer Research. 38, 1, 157.

    Research output: Contribution to journal › Article

    Open Access
    • 4 Scopus citations

    Inhibition of USP14 enhances the sensitivity of breast cancer to enzalutamide

    Xia, X., Huang, C., Liao, Y., Liu, Y., He, J., Guo, Z., Jiang, L., Wang, X., Liu, J. & Huang, H., May 24 2019, In : Journal of Experimental and Clinical Cancer Research. 38, 1, 220.

    Research output: Contribution to journal › Article

    Open Access
    • 8 Scopus citations